Targeting HER2 as a therapeutic strategy for breast cancer: a paradigmatic shift of drug development in oncologyMichelino De Laurentiis, Sabino De Placido, Luca Malorni et al.|Annals of Oncology|2005Cited by 49
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologistsMargaret Ottaviano, Vincenzo Montesarchio, Marcello Curvietto et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 19